COVID-19 is affecting a large part of the world’s population, especially those with pre-existing bronchopulmonary conditions, with acute manifestations in the respiratory system, the most evident of which is pneumonia that can lead to hospitalization of patients affected by severe respiratory failure, which in turn can lead to a situation of acute respiratory crisis, and in many cases, death of the patient. Apart from this, many people who have recovered from the disease are now experiencing post-COVID-19 effects, such as difficulty breathing, fatigue, and lack of oxygen in the blood, among others, making it difficult to carry out tasks that were previously routine and effortless.
Currently, in Brazil, Asmazol is being used to treat respiratory crises in COVID-19 patients with excellent results. The positive effects of this natural medicine, originally created to treat asthma and other respiratory system conditions, allow people to experience relief from suffocation crises caused by the coronavirus.
Consider the following reasons why Asmazol effectively acts against crises caused by COVID-19:
COVID-19 takes advantage of low immunity in the person to attack – Asmazol strengthens the immune system.
COVID-19 inflames the respiratory tract causing suffocation in the person – Asmazol is a powerful anti-inflammatory.
COVID-19 causes severe pain in the respiratory system – Asmazol is also an analgesic.
COVID-19 blocks breathing by causing bronchio-constriction, producing blood clots in the lungs – Asmazol is a dilator that oxygenates blood vessels.
In other words, everything bad caused by COVID-19, Asmazol reverses.
The emphasis has been on the solution of asthma and other respiratory illnesses, however, many companies have worked tirelessly to find the necessary solutions when caught off guard by this malignant virus of COVID-19.
As Asmazol has the aforementioned properties, it is simply logical to think that it brings great relief to the person affected by the virus, which has already been proven in hundreds of people, and in the process, it is being requested for that purpose more frequently every day.
Asmazol is for short-term use, does not cause side effects, does not generate dependence, and can be used in infants from three months old to elderly people.
Every person who has pre-existing respiratory conditions or a family member living with them (even if they have not contracted the virus) should have Asmazol at their disposal in their homes to be used as the first line of preventive aid against possible Coronavirus contagion.
